Both Ly-1 B cells and conventional B cells make autoantibodies to bromelain-treated autologous erythrocytes
Andrew, E.; Annis, W.; Maini, R.N.
Advances in Experimental Medicine and Biology 237: 119-123
1988
ISSN/ISBN: 0065-2598 PMID: 3075844 Document Number: 313449
Document emailed within 1 workday
Related Documents
Nowaczyk, M.; Skopińska-Rózewska, E. 1981: The influence of autologous erythrocytes on active T-cells rosetting with sheep red blood cells and on DNA synthesis Archivum Immunologiae et Therapiae Experimentalis 29(3): 391-396Kabelitz, D.; Tötterman, T.H.; Nilsson, K.; Gidlund, M. 1984: Phorbol ester treated chronic B lymphocytic leukaemia cells induce autologous T cell proliferation without generation of cytotoxic T cells Clinical and Experimental Immunology 57(2): 461-466
Kasemkijwattana, C.; Rungsinaporn, V.; Siripisitsak, T.; Kongmalai, P.; Boonprasert, R.; Charoenthamruksa, C.; Hongeng, S.; Wongkajornsilp, A.; Muangsomboon, S.; Chaipinyo, K.; Chansiri, K. 2016: Autologous Fibrin-Base Scaffold for Chondrocytes and Bone Marrow Mesenchymal Stem Cells Implantation: The Development and Comparison to Conventional Fibrin Glue Journal of the Medical Association of Thailand 99 Suppl. 8: S99
Mirakian, R.; Bottazzo, G.F.; Doniach, D. 1980: Autoantibodies to duodenal gastric-inhibitory-peptide (GIP) cells and to secretin (S) cells in patients with coeliac disease, tropical sprue and maturity-onset diabetes Clinical and Experimental Immunology 41(1): 33-42
Guo, Y.S.; Xing, Z.L. 1994: A study of the cytotoxicity of malignant pleural effusion lymphocytes and LAK cells against autologous tumor cells Chinese Medical Journal 107(12): 903-905
Murohashi, I.; Nagata, K.; Suzuki, T.; Yamashita, Y.; Maruyama, Y.; Nara, N. 1988: Production of growth potentiating factor(s) for autologous blast cells by acute myeloblastic leukemia cells Cancer Research 48(22): 6424-6428
Tomonari, K.; Aizawa, M. 1979: Induction of autoreactive cells by the preculture of human peripheral blood mononuclear cells with the autologous fresh plasma Journal of Immunology 122(6): 2478-2483
Yanagisawa, M.; Kato, M.; Ikeno, K.; Kobayashi, T.; Miyagawa, Y.; Komiyama, A.; Akabane, T. 1987: Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection Clinical and Experimental Immunology 68(2): 251-258
Danersund, A.; Tötterman, T.H.; Nilsson, K.; Egle-Jansson, I.; Kabelitz, D.; Sjöberg, O. 1985: Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells Clinical and Experimental Immunology 59(3): 644-652
Itoh, K.; Tilden, A.B.; Balch, C.M. 1985: Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cells Cancer Research 45(7): 3173-3178
Taylor, R.S.; Baadsgaard, O.; Hammerberg, C.; Cooper, K.D. 1991: Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis Journal of Immunology 147(11): 3794-3802
Sorette, M.P.; Clark, M.R. 1991: Specificity of autologous antibody binding to phenylhydrazine-treated human erythrocytes: implications for models of red blood cell aging Journal of Laboratory and Clinical Medicine 117(6): 477-484
Molinaro, G.A.; Sato, K.; Paque, R.E.; Dray, S. 1975: Rosetting of antibody-sensitized tumor cells with anti-immunoglobulin antibody-coated erythrocytes by a new method for detecting antigens on cells Cancer Research 35(8): 2213-2216
Lopez, M.; Mortel, O.; Pouillart, P.; Zucker, J.M.; Fechtenbaum, J.; Douay, L.; Palangie, T.; Michon, J.; Salmon, D. 1990: Infusion of autologous peripheral blood nucleated cells hastens hematological recovery after high dose chemotherapy and autologous transplantation of bone marrow Bone Marrow Transplantation 5 Suppl. 1: 44-45
Nair, S.K.; Snyder, D.; Gilboa, E. 1996: Cells treated with TAP-2 antisense oligonucleotides are potent antigen-presenting cells in vitro and in vivo Journal of Immunology 156(5): 1772-1780
Levy, R.B.; Shearer, G.M.; Richardson, J.C.; Henkart, P.A. 1981: Cell-mediated lympholytic responses against autologous cells modified with haptenic sulfhydryl reagents. I. Effector cells can recognize two distinct classes of hapten-reactive self sites on cell surface proteins Journal of Immunology 127(2): 523-528
Levy, E.M.; Kumar, V.; Bennett, M. 1981: Natural killer activity and suppressor cells in irradiated mice repopulated with a mixture of cells from normal and 89Sr-treated donors Journal of Immunology 127(4): 1428-1432
Hoover, H.C.; Surdyke, M.; Dangel, R.B.; Peters, L.C.; Hanna, M.G. 1984: Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with an autologous tumor cell: Bacillus Calmette-Guérin vaccine Cancer Research 44(4): 1671-1676
Gordon, J.; Murgita, R.A.; Tomasi, T.B. 1975: The immune response of mice treated with anti-mu antibodies: the effect on antibody-forming cells, their precursors and helper cells assayed in vitro Journal of Immunology 114(6): 1808-1812
Harada, M.; Omoto, K.; Kimura, G.; Nomoto, K. 1995: Priming with donor spleen cells and activated B cells can induce prolonged survival of class I-disparate skin allografts in cyclophosphamide-treated mice Transplantation 60(5): 517-519